Skip to content

H.R. 767 · 118th Congress (2023–2025)

Protecting Access to Medication Abortion Act of 2023

This bill requires the Food and Drug Administration (FDA) to ensure that patients may receive mifepristone through prescriptions issued via telehealth and filled by mail. The FDA has approved mifepristone for medication abortions (i.e., a procedure in which prescription drugs are used to terminate a pregnancy).

(Mifepristone is subject to a Risk Evaluation and Mitigation Strategy, which imposes various safety-related requirements. During the COVID-19 public health emergency, the FDA suspended enforcement of a requirement that the drug must be dispensed in person, a requirement in the strategy at the time. In January 2023, the FDA updated the strategy to remove the in-person dispensing requirement.)

Under this bill, the FDA must ensure that the strategy for mifepristone (1) does not have an in-person dispensing requirement, (2) allows patients to access prescriptions for mifepristone via telehealth, and (3) authorizes all pharmacies certified to dispense mifepristone to patients to do so via mail.

Show official title

To preserve access to abortion medications.

Expired in House committee

Derived from the legislative history, not an official disposition.

Latest actionReferred to Health

This bill’s path

This is H.R. 767’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

  6. Expired

Sponsor
Rep. Cori Bush (D-MO-1)
Cosponsors
30 cosponsors

7 original · 23 later

30 D

  1. Rep. Donald S. Beyer, Jr. (D-VA-8)· Original · Feb 2, 2023
  2. Rep. André Carson (D-IN-7)· Original · Feb 2, 2023
  3. Rep. Sheila Jackson Lee (D-TX-18)· Original · Feb 2, 2023
  4. Rep. Betty McCollum (D-MN-4)· Original · Feb 2, 2023
  5. Del. Eleanor Holmes Norton (D-DC)· Original · Feb 2, 2023
  6. Rep. Ilhan Omar (D-MN-5)· Original · Feb 2, 2023
  7. Rep. Darren Soto (D-FL-9)· Original · Feb 2, 2023
  8. Rep. Gwen Moore (D-WI-4)· Later · Feb 7, 2023
  9. Rep. Ted Lieu (D-CA-36)· Later · Feb 14, 2023
  10. Rep. Chellie Pingree (D-ME-1)· Later · Feb 14, 2023
  11. Rep. Greg Casar (D-TX-35)· Later · Feb 27, 2023
  12. Rep. Mary Gay Scanlon (D-PA-5)· Later · Feb 28, 2023
  13. Rep. Jamaal Bowman (D-NY-16)· Later · Mar 7, 2023
  14. Rep. Becca Balint (D-VT)· Later · Mar 7, 2023
  15. Rep. Adam B. Schiff (D-CA-28)· Later · Mar 7, 2023
  16. Rep. Nanette Diaz Barragán (D-CA-44)· Later · Mar 8, 2023
  17. Rep. Ayanna Pressley (D-MA-7)· Later · Mar 21, 2023
  18. Rep. Jill N. Tokuda (D-HI-2)· Later · Mar 21, 2023
  19. Rep. Deborah K. Ross (D-NC-2)· Later · Mar 30, 2023
  20. Rep. Jesús G. "Chuy" García (D-IL-4)· Later · Apr 10, 2023
  21. Rep. Donald M. Payne, Jr. (D-NJ-10)· Later · Apr 10, 2023
  22. Rep. Sydney Kamlager-Dove (D-CA-37)· Later · Apr 17, 2023
  23. Rep. Kevin Mullin (D-CA-15)· Later · Apr 17, 2023
  24. Rep. Jahana Hayes (D-CT-5)· Later · Apr 19, 2023
  25. Rep. Mary Sattler Peltola (D-AK)· Later · May 9, 2023
  26. Rep. Daniel S. Goldman (D-NY-10)· Later · Aug 25, 2023
  27. Rep. Steve Cohen (D-TN-9)· Later · Dec 19, 2023
  28. Rep. Susie Lee (D-NV-3)· Later · Apr 9, 2024
  29. Rep. Dean Phillips (D-MN-3)· Later · May 14, 2024
  30. Rep. Andrea Salinas (D-OR-6)· Later · Nov 8, 2024
Policy area
Health
Subjects
  • Abortion
  • Health care coverage and access
  • Health technology, devices, supplies
  • Prescription drugs

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest
    ▸ 2 committee actions · Feb 2, 2023 – Feb 10, 2023
    1. Referred to committee

      Referred to the House Committee on Energy and Commerce.

      Sources
    2. Referred to Health

      Referred to the Subcommittee on Health.

      Sources
  3. Expired

    Introduced → Referred to House Health → No further action before the 118th Congress ended.

Committees

  1. HouseEnergy and CommerceReferred Feb 2, 2023
  2. HouseHealthReferred Feb 10, 2023

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (2)
  1. Protecting Access to Medication Abortion Act of 2023

    Display title, Short title · Introduced in House

  2. To preserve access to abortion medications.

    Official title · Introduced in House